Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...

One of the biggest names in adult entertainment, Emily Willis, has been left permanently disabled after checking into a Malibu rehab center for drug addiction treatment, ...

A team of US-based scientists have found "a probable causal connection" between a form of bacteria found in the human gut and the onset of depression.Carried out by a team from Harvard University and ...

Explore how political divisiveness impacts mental health and amplifies high-functioning depression, and discover strategies ...

Hers breaks down the winter blues, what causes them, and research-backed tips for handling this seasonal mood change.

Sarah Chihaya’s unconventional memoir charts her troubled relationship with the literature that formed her.

Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide ...

The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adults. The latest nod diversifies its commercial portfolio.

Advanced puberty in preadolescence was associated with increased likelihood of experiencing self-injurious thoughts and behaviors in the future.

ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 360,300 ...